InvestyWise InvestyWise
  • Home
  • News
    • Corporate Action
    • Company Results
    • Board Meeting
    • Company Update
    • Insider Trading / SAST
    • Corporate Announcements
    • Other Announcements

InvestyWise InvestyWise

  • Home
  • News
    • Corporate Action
    • Company Results
    • Board Meeting
    • Company Update
    • Insider Trading / SAST
    • Corporate Announcements
    • Other Announcements
InvestyWise InvestyWise

What are You Looking For?

  • Company Update
  • Board Meeting
  • Company Results
  • Insider Trading / SAST
  • Other Announcements
  • Corporate Action

Explore Trending Topics

Company Update
Board Meeting
Company Results
Insider Trading / SAST
  • Company Update
2 Min Read
InvestyWise News
onNovember 13, 2025

Granules India Q2 FY26 Earnings Show Strong Growth in Formulations

Granules India reported a robust Q2 FY26, driven by formulations growth in North America and Europe. Sales increased, with EBITDA rising due…
  • Company Update
2 Min Read
InvestyWise News
onNovember 13, 2025

Granules India Q2 FY26 Revenue Up 34% YoY, PAT Rises 34%

Granules India announced a strong financial performance for the second quarter of fiscal year 2026 (Jul-Sep). Revenue from operations…
  • Company Update
2 Min Read
InvestyWise News
onNovember 13, 2025

Alkem Laboratories Q2 FY26 Revenue Up 17%, EBITDA Surges 22%

Alkem Laboratories announced a strong performance in Q2 FY26, with revenue increasing by 17.2% to ₹40,010 Mn. The company’s EBITDA grew…
  • Company Update
1 Min Read
InvestyWise News
onNovember 13, 2025

Zydus Lifesciences Receives USFDA Approval for Diroximel Fumarate Capsules

Zydus Lifesciences has secured tentative approval from the USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg. These capsules are…
  • Board Meeting
2 Min Read
InvestyWise News
onNovember 13, 2025

Granules India Acquisition and Financial Results Announcement

Granules India has announced the approval of its unaudited financial results for Q2 FY26, the acquisition of optus 1039, GmBH in Germany, and…
  • Company Results
1 Min Read
InvestyWise News
onNovember 13, 2025

Alkem Laboratories Reports 17% Revenue Growth, 22% EBITDA Growth in Q2 FY26

Alkem Laboratories announced a 17% YoY revenue increase to ₹40,010 Mn and a 22% YoY growth in EBITDA to ₹9,208 Mn in Q2 FY26. Domestic sales…
  • Board Meeting
1 Min Read
InvestyWise News
onNovember 13, 2025

Alkem Laboratories Reports Consolidated Financial Results for Q2 2026

Alkem Laboratories has announced its consolidated financial results for Q2 2026. The company reported a total income of ₹41,046.8 million and…
  • Company Results
1 Min Read
InvestyWise News
onNovember 13, 2025

Ipca Laboratories Q2/H1 FY26 Financial Results Show Strong Growth

Ipca Laboratories announced unaudited financial results for Q2 and H1 FY26. Standalone net total income increased by 7% to ₹1952.24 crores,…
  • Company Update
1 Min Read
InvestyWise News
onNovember 13, 2025

KSB Limited Strong Q2 Results with 5.4% Sales Increase

KSB Limited announced a strong Q2 2025 with sales up 5.4% to ₹649.6 crores. The company secured key contracts, including a ₹53.6 crore export…
  • Board Meeting
2 Min Read
InvestyWise News
onNovember 13, 2025

Ipca Laboratories Reports Strong Q2 & H1 FY26 Financial Performance

Ipca Laboratories announced a robust financial performance for Q2 and H1 FY26. Standalone Net Total Income increased by 7% to ₹1952.24 crores.…

Posts pagination

Previous 1 … 1,506 1,507 1,508 … 2,131 Next
InvestyWise InvestyWise
  • Home
    • About Us
    • Privacy Policy
    • Refunds & Cancellations
    • Terms & Conditions
© 2025 — InvestyWise. All Rights Reserved.